Lets Get CB-03-01 DONE. We are SO close.

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Gjm127
    Senior Member
    • Mar 2012
    • 171

    On Cosmo's site, it now says this when on CB-03-01 section... I don't know if it's been newly updated or not. What's up with this patient? October 2014, that's like... now lol

    ****The first patient in for a “proof of concept” phase II trial for alopecia is expected in October 2014.
    Two patent families have been filed. Patents have been granted in the US expiring in 2023 and 2030.
    CB-03-01 is unlicensed****

    Comment

    • hellouser
      Senior Member
      • May 2012
      • 4423

      Originally posted by Gjm127
      On Cosmo's site, it now says this when on CB-03-01 section... I don't know if it's been newly updated or not. What's up with this patient? October 2014, that's like... now lol

      ****The first patient in for a “proof of concept” phase II trial for alopecia is expected in October 2014.
      Two patent families have been filed. Patents have been granted in the US expiring in 2023 and 2030.
      CB-03-01 is unlicensed****
      Patent or Patient? And what's the link??????

      Comment

      • pagedo
        Junior Member
        • Oct 2014
        • 21

        Originally posted by hellouser
        Patent or Patient? And what's the link??????

        Comment

        • hellouser
          Senior Member
          • May 2012
          • 4423

          All that link tells me is that biotechs continually give bald men the middle finger.

          Comment

          • FearTheLoss
            Senior Member
            • Dec 2012
            • 1589

            Damn, did they lose their licensing? I thought they had already licensed CB?

            Comment

            • FearTheLoss
              Senior Member
              • Dec 2012
              • 1589

              I guess the good news is they are starting phase II..the bad news is it looks as if they lost their licensing partner and they are focusing more on colon treatments.

              Comment

              • Boldy
                Senior Member
                • Jan 2013
                • 287

                The objective is to create a product for topical application to treat acne, male pattern baldness, and hirsutism that does not have the side effects of products currently being taken in tablet form.
                what they basically say here is that topical drugs with low halflife don't have the sideffect profile of oral drugs, that is pretty logical thus far.

                Im curious to their phase 3 tials, where not only the most healthy people take a place in the trial, if they will experience the same sides that some of us had with cb. in phase 1 and 2 they make sure they have the healthiest subjects.

                Phase 3 studies begin if evidence of effectiveness is shown in Phase 2. These studies gather more information about safety and effectiveness, studying different populations and different dosages and using the drug in combination with other drugs. The number of subjects usually ranges from several hundred to about 3,000 people.

                Comment

                • burtandernie
                  Senior Member
                  • Nov 2012
                  • 1568

                  Yeah lets hope it gets licensed. Its not going to move very fast without someone licensing it and pushing it through. The biggest worry is its turn into RU and never gets funded to the finish line. If CB doesnt happen its going to be a very long wait for new treatments

                  Comment

                  • lifelonglearning
                    Member
                    • Jun 2014
                    • 69

                    From a shareholders perpsective

                    If i was a shareholder I would not be happy that the company is pursing the acne verson first, isn't the potential revenues greater in the male pattern hair loss sector?

                    If this is the case wouldn't it be possible to put pressure on directors by circulated something like a memo to all shareholders to get them to agree that the company should be going for male pattern baldness first. I forget what the term is called... shareholder dissident circular?

                    Comment

                    • burtandernie
                      Senior Member
                      • Nov 2012
                      • 1568

                      Is cosmo pursuing acne with cb 03 01 themselves? Dont they normally just license it out to someone else?

                      Comment

                      • Gjm127
                        Senior Member
                        • Mar 2012
                        • 171

                        They're apparently also developing CB for MPB other than Cosmo. Has this been posted before?



                        While I'm at it, when is Cosmo releasing their acne product? Where are they in their clinical trials?

                        Comment

                        • breakbot
                          Senior Member
                          • Feb 2014
                          • 101

                          Originally posted by Gjm127
                          They're apparently also developing CB for MPB other than Cosmo. Has this been posted before?



                          While I'm at it, when is Cosmo releasing their acne product? Where are they in their clinical trials?
                          It's not cb. This is another antiandrogen which is only developing for acne.It was supposed to be tested for AGA but it didn't. In my opinion it's mechanism is superior than cb. It is supposed to destroy the androgen receptors, an amazing mechanism of prevention. I'm impressed they didn't tried to bring it to trials for alopecia yet.

                          Cosmo completed phase 2 for acne recently.

                          Comment

                          • Gjm127
                            Senior Member
                            • Mar 2012
                            • 171

                            Originally posted by breakbot
                            It's not cb. This is another antiandrogen which is only developing for acne.It was supposed to be tested for AGA but it didn't. In my opinion it's mechanism is superior than cb. It is supposed to destroy the androgen receptors, an amazing mechanism of prevention. I'm impressed they didn't tried to bring it to trials for alopecia yet.

                            Cosmo completed phase 2 for acne recently.
                            so since they're filing for phase 3, what's the timeline now for the acne version?

                            Comment

                            • Sogeking
                              Senior Member
                              • Feb 2011
                              • 497

                              Originally posted by Gjm127
                              so since they're filing for phase 3, what's the timeline now for the acne version?
                              I guess 2016. but don't take my word for it. However those trials are interesting to us because of safety.

                              Comment

                              • inbrugge
                                Senior Member
                                • Oct 2013
                                • 244

                                Originally posted by breakbot
                                It's not cb. This is another antiandrogen which is only developing for acne.It was supposed to be tested for AGA but it didn't. In my opinion it's mechanism is superior than cb. It is supposed to destroy the androgen receptors, an amazing mechanism of prevention. I'm impressed they didn't tried to bring it to trials for alopecia yet.

                                Cosmo completed phase 2 for acne recently.
                                Smh...How many more treatments do we need for acne already?

                                Comment

                                Working...